Tolochko Christina, Shiryaeva Olga, Alekseeva Tatiana, Dyachuk Vyacheslav
V. A. Almazov Federal National Medical Research Centre, Saint Petersburg 197341, Russia.
Research Laboratory of Neurogenesis and Neurodegenerative Diseases, V. A. Almazov Federal National Medical Research Centre, Saint Petersburg 197341, Russia.
Int J Mol Sci. 2025 May 29;26(11):5240. doi: 10.3390/ijms26115240.
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease associated with damage to motor neurons and leading to severe muscle weakness and, eventually, death. Over the past decade, understanding of the key pathogenetic links of ALS, including glutamate-mediated excitotoxicity and oxidative stress, has significantly advanced. This review considers the recent evidence on molecular mechanisms of these processes, as well as the therapeutic strategies aimed at their modulation. Special attention is paid to antiglutamatergic and antioxidant drugs as approaches to the ALS pathogenetic therapy.
肌萎缩侧索硬化症(ALS)是一种进行性神经退行性疾病,与运动神经元损伤相关,会导致严重的肌肉无力,并最终导致死亡。在过去十年中,对ALS关键发病机制的理解取得了显著进展,其中包括谷氨酸介导的兴奋性毒性和氧化应激。本综述探讨了这些过程分子机制的最新证据,以及旨在调节这些机制的治疗策略。特别关注抗谷氨酸能药物和抗氧化药物作为ALS发病机制治疗方法的研究。